In May 2018, Medicilon’s clinical pathology laboratory passed the inspection of interventricular quality evaluation from Shanghai Center for Clinical Laboratory. EQA (external quality assessment)
In recent years, the environment of biological new drug development has improved rapidly. From the policy environment of new drug research and development, the State
Greater than 90% of all Alzheimer’s disease (AD) cases are sporadic, meaning there are few hereditary risk factors for developing the disease. Although certain genetic
Proficiency Testing (PT) is an important tool to enhance the quality management of the laboratory and to evaluate and improve the technical capabilities of the
